Form 4 for AKBA Akebia Therapeutics, Inc.
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-17 · accession 0001562180-25-000453 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-22 | 2025-01-17 | AKBA | FRIESON RON | Dir | M - OptEx | $0.45 | +20.1K | 93.8K | +27% | +$9,045 |
| D | 2025-01-22 | 2025-01-17 | AKBA | FRIESON RON | Dir | M - OptEx | $0.00 | -20.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-17 | M | A | 20,100 | $0.45 | 93,800 | D | — | — | |
| 2 | Derivative | Stock Option (Right to buy) | 2025-01-17 | M | D | 20,100 | $0.00 | 0 | D | $0.45 · 2023-06-08 to 2032-06-08 | 20,100 Common Stock |